Mechanistic Studies of B- and T-Cell Function in Rheumatoid Arthritis Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept
Phase of Trial: Phase IV
Latest Information Update: 19 Aug 2017
At a glance
- Drugs Abatacept (Primary) ; Tocilizumab (Primary) ; Certolizumab pegol
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- Acronyms MAZERATI
- 08 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
- 10 Jun 2017 Biomarkers information updated
- 14 Jan 2016 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.